| Literature DB >> 35215506 |
Menno Henselmans1, Thomas Bjørnsen2, Richie Hedderman1, Fredrik Tonstad Vårvik1,2.
Abstract
High carbohydrate intakes are commonly recommended for athletes of various sports, including strength trainees, to optimize performance. However, the effect of carbohydrate intake on strength training performance has not been systematically analyzed. A systematic literature search was conducted for trials that manipulated carbohydrate intake, including supplements, and measured strength, resistance training or power either acutely or after a diet and strength training program. Studies were categorized as either (1) acute supplementation, (2) exercise-induced glycogen depletion with subsequent carbohydrate manipulation, (3) short-term (2-7 days) carbohydrate manipulation or (4) changes in performance after longer-term diet manipulation and strength training. Forty-nine studies were included: 19 acute, six glycogen depletion, seven short-term and 17 long-term studies. Participants were strength trainees or athletes (39 studies), recreationally active (six studies) or untrained (four studies). Acutely, higher carbohydrate intake did not improve performance in 13 studies and enhanced performance in six studies, primarily in those with fasted control groups and workouts with over 10 sets per muscle group. One study found that a carbohydrate meal improved performance compared to water but not in comparison to a sensory-matched placebo breakfast. There was no evidence of a dose-response effect. After glycogen depletion, carbohydrate supplementation improved performance in three studies compared to placebo, in particular during bi-daily workouts, but not in research with isocaloric controls. None of the seven short-term studies found beneficial effects of carbohydrate manipulation. Longer-term changes in performance were not influenced by carbohydrate intake in 15 studies; one study favored the higher- and one the lower-carbohydrate condition. Carbohydrate intake per se is unlikely to strength training performance in a fed state in workouts consisting of up to 10 sets per muscle group. Performance during higher volumes may benefit from carbohydrates, but more studies with isocaloric control groups, sensory-matched placebos and locally measured glycogen depletion are needed.Entities:
Keywords: carbohydrate intake; muscle strength; performance; resistance exercise
Mesh:
Substances:
Year: 2022 PMID: 35215506 PMCID: PMC8878406 DOI: 10.3390/nu14040856
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow chart of the study selection process.
Summary of study quality assessment in acute-, glycogen depletion- and short-term studies.
| Criterion |
| % | |
|---|---|---|---|
| Study quality | 1. Eligibility criteria specified | 21 | 66 |
| 2. Randomization specified | 5 | 16 | |
| 3. Allocation concealment | 30 | 94 | |
| 4. Groups similar at baseline | 32 | 100 | |
| 5. Blinding of assessor (for at least one key outcome) | 16 | 50 | |
| Study reporting | 6a. Outcome measures assesses in 85% of participants | 30 | 94 |
| 6b. Adverse events reported | 1 | 3 | |
| 8a. Between-group statistics reported—primary | 32 | 100 | |
| 8b. Between-group statistics reported—secondary | 32 | 100 | |
| 9. Points measures and measures of variability reported | 31 | 97 | |
| 12. Exercise volume and energy expenditure | 29 | 91 |
1 = criteria met; 0 = criteria not met; n = number of studies meeting criteria: % = percentage of studies meeting criteria. Thirty-one studies in total.
Summary of study quality assessment in long-term studies.
| Criterion |
| % | |
|---|---|---|---|
| Study quality | 1. Eligibility criteria specified | 16 | 94 |
| 2. Randomization specified | 0 | 0 | |
| 3. Allocation concealment | 12 | 71 | |
| 4. Groups similar at baseline | 15 | 88 | |
| 5. Blinding of assessor (for at least one key outcome) | 1 | 6 | |
| Study reporting | 6a. Outcome measures assesses in 85% of participants | 14 | 82 |
| 6b. Adverse events reported | 7 | 41 | |
| 6c. Exercise attendance reported | 13 | 76 | |
| 7. Intention-to-treat analysis | 7 | 41 | |
| 8a. Between-group statistics reported—primary | 17 | 100 | |
| 8b. Between-group statistics reported—secondary | 17 | 100 | |
| 9. Points measures and measures of variability reported | 17 | 100 | |
| 11. Relative exercise intensity remained constant | 16 | 94 | |
| 12. Exercise volume and energy expenditure | 5 | 29 |
1 = criteria met; 0 = criteria not met; n = number of studies meeting criteria: % = percentage of studies meeting criteria. Fourteen studies in total.
Study quality assessment of the acute-, glycogen depletion- and short-term studies.
| Study | 1 | 2 | 3 | 4 | 5 | 6a | 6b | 8a | 8b | 9 | 12 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute studies | ||||||||||||
| Baty et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 10 |
| Dalton et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Fairchild et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 10 |
| Fayh et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Haff et al. [ | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Krings et al. [ | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
| Kulik et al. [ | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
| Lambert et al. [ | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Laurenson-Dubè [ | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 7 |
| Lynch et al. [ | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Maroufi et al. [ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 8 |
| Naharudin et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Naharudin et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 10 |
| Raposo [ | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Rountree et al. [ | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
| Santos et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Smith et al. [ | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
| Welikonich [ | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 7 |
| Wilburn et al. [ | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
| Glycogen-depletion studies | ||||||||||||
| Haff et al. [ | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Haff et al. [ | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Leveritt-Abernethy [ | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 6 |
| Mitchell et al. [ | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 7 |
| Oliver et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 10 |
| Symons-Jacobs [ | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 7 |
| Short-term studies | ||||||||||||
| Dipla et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Escobar et al. [ | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 7 |
| Hatfield et al. [ | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 7 |
| Kreider et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 6 |
| Meirelles et al. [ | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
| Moura et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
| Sawyer et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 8 |
1 = criteria met; 0 = criteria not met. Criteria 1; eligibility criteria specified, 2; randomization method specified, 3; allocation concealment, 4; groups similar at baseline, 5; blinding of assessor; 6a; outcome measures assessed in 85% of subjects, 6b; adverse events reported, 8; between group statistical comparisons reported (a; primary outcome, b; secondary outcome) 9; point measures and measures of variability of outcomes reported, 12; reported exercise volume and energy expenditure.
Study quality assessment of the longer-term studies.
| Study | 1 | 2 | 3 | 4 | 5 | 6a | 6b | 6c | 7 | 8a | 8b | 9 | 11 | 12 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agee [ | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
| Greene et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 * | 0 | 9 |
| Gregory et al. [ | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 * | 0 | 11 |
| Kephart et al. [ | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 * | 0 | 8 |
| Kreider et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 * | 1 | 1 | 1 | 1 | 0 | 11 |
| LaFountain et al. [ | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 10 |
| Meirelles-Gomes [ | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 * | 1 | 1 | 1 | 1 | 1 | 11 |
| Michalski et al. [ | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 * | 0 | 8 |
| De Oliveira et al. [ | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 * | 1 | 1 | 1 | 1 | 0 | 8 |
| Paoli et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 * | 1 | 1 | 1 | 1 * | 0 | 11 |
| Paoli et al. [ | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 * | 1 | 1 | 1 | 1 * | 0 | 9 |
| Rhyu and Cho [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 * | 1 | 1 | 1 | 1 * | 0 | 9 |
| Rozenek et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 10 |
| Van Zant et al. [ | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 * | 1 | 1 | 1 | 1 * | 0 | 9 |
| Vargas-Molina et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 8 |
| Vidić et al. [ | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 8 |
| Wilson et al. [ | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
1 = criteria met; 0 = criteria not met. Criteria 1; eligibility criteria specified, 2; randomization method specified, 3; allocation concealment, 4; groups similar at baseline, 5; blinding of assessor, 6a; outcome measures assessed in 85% of subjects, 6b; adverse events reported, 6c; exercise attendance reported, 7; intention-to-treat analysis (*: 1 point was given if there were no dropouts and therefore no need for an intention-to-treat analysis), 8; between group statistical comparisons reported (a; primary outcome, b; secondary outcome), 9; point measures and measures of variability of outcomes reported, 11; relative exercise intensity remained constant (*: 1 point was given if the participants were athletes or strength trainees and followed their regular training program), 12; reported exercise volume and energy expenditure.
The acute effect of carbohydrate ingestion on strength training performance.
| Study | Design and Population | Training Protocol and Performance Outcomes | Carbohydrate (CHO) Intakes | Fasted or Fed | Results |
|---|---|---|---|---|---|
| Baty et al. [ | RCT: | Fasted | No significant differences between conditions in weight lifted the last set or total training volume (total load CHO-PRO: 534 ± 80 kg vs. placebo: 556 ± 82 kg; weight scaled per lean body mass × repetitions CHO-PRO: 93 ± 17 vs. placebo: 92 ± 21). | ||
| Dalton et al. [ | RCT: | Overnight fasted. | No significant differences in repetitions to failure between conditions (knee extension CHO: 17 ± 1, placebo: 17 ± 2, control: 17 ± 2; bench press CHO: 17 ± 2, placebo: 17 ± 2, control: 16 ± 3). | ||
| Fairchild et al. [ | Counterbalanced crossover: | Fasted | There was no interaction effect but when adjusting for baseline values a significant main effect between conditions were observed where the CHO condition resulted in a decline (~2%-points) and maintenance in average and peak torque, respectively, compared to an increase (~4–5%-points) in both for placebo. | ||
| Fayh et al. [ | Crossover: | Fed | No significant differences in total training volume between conditions (CHO: 12,944 ± 2548 kg vs. placebo: 12,876 ± 2025 kg). | ||
| Haff et al. [ | Crossover: | Fed | Significant greater total work (CHO: 24 ± 2 J, placebo: 22 ± 2 J), average work (CHO: 1.5 ± 0.1 J, placebo: 1.4 ± 0.5 J), and average torque per set (CHO: 105 ± 8 Nm, placebo: 98 ± 8 Nm) in knee extension in the CHO condition. No differences were observed between conditions in peak torque in the knee extension or any of the measurements for the knee flexors. | ||
| Krings et al. [ | Crossover: | Fasted | No significant differences in total repetitions between CHOs and placebo, but 15 g/h > 60 g/h. For the bench press, all CHO groups outperformed placebo without dose-response. No significant differences for the other three exercises, two jumps or four run times, except 60 g/h > placebo for the 27-m sprint. | ||
| Kulik et al. [ | Counterbalanced crossover: Strength-trained men ( | Fed | No significant differences between conditions in repetitions and sets to failure or volume load and total load (repetitions CHO: 20 ± 15 vs. placebo: 20 ± 13, sets CHO: 4 ± 3 vs. placebo: 4 ± 3, volume load CHO: 2929 ± 2220 kg vs. placebo: 2773 ± 1951 kg, work CHO: 30 ± 22 kJ vs. placebo: 29 ± 20 kJ). | ||
| Lambert et al. [ | Crossover: | Relatively fed | No significant difference in repetitions and sets to failure between the conditions. However, there was a tendency for more repetitions (149 ± 16 vs. 129 ± 12, | ||
| Laurenson and Dubé [ | Crossover: | Fasted | Significantly more total bench press volume in the CHO condition (921 ± 365 vs. 783 ± 332). However, no differences was observed in total squat volume (CHO: 1009 ± 433 vs. 909 ± 472, | ||
| Lynch [ | Crossover: | Not specified. | No significant difference between conditions in agility T-test, push-ups to failure or sprint. However, analyzing all three performance variables simultaneously yielded a significant greater effect of the high-protein condition compared to the carbohydrate condition. | ||
| Maroufi et al. [ | Crossover: | Fasted | No significant difference between conditions in repetitions to failure (3:1 ratio 341 ± 56, 2:2 ratio 366 ± 61, placebo 346 ± 65). | ||
| Naharudin et al. [ | Counterbalanced crossover: | Fasted | Significantly more repetitions to failure in the CHO condition for squat (68 ± 14 vs. placebo: 58 ± 11, effect size [ES] = 0.98) and bench press (40 ± 5 vs. placebo: 38 ± 5, ES = 1.06). | ||
| Naharudin et al. [ | Counterbalanced crossover: | Fasted | Significantly more repetitions to failure in the CHO and placebo breakfast conditions in the squat exercise (CHO: 44 ± 10, placebo: 43 ± 10, water-only: 38 ± 10), but not during bench press (CHO: 39 ± 7, placebo: 38 ± 7, water-only: 37 ± 7). While there was no significant difference in repetitions completed in the CHO- vs. the placebo condition. | ||
| Raposo et al. [ | Counterbalanced crossover: | Fasted (overnight). | No significant differences between conditions in repetitions to failure and training volume (repetitions bench press, CHO: 45 ± 11 vs. 45 ± 10; leg press, CHO: 112 ± 59 vs. 98 ± 38. Training volume bench press, CHO: 1451 ± 414 vs. 1430 ± 387; leg press, CHO: 19,960 ± 13,477 vs. 17,103 ± 8927). | ||
| Rountree et al. [ | Crossover: | Fasted | No significant differences between conditions in repetitions to failure (total repetitions CHO: 279 vs. placebo: 272) and caloric expenditure during 1 min all out rowing (kilocalories CHO: 42 vs. placebo: 45). | ||
| Santos et al. [ | Crossover: | Not specified. | Significantly more repetitions in the CHO condition (13 ± 2 vs. 11 ± 2). | ||
| Smith et al. [ | Crossover: | Fasted | No significant time × treatment interactions for any exercise for repetition performance. However, there was a treatment effect for CHO + BCAA compared to the other treatments, but it was confounded by an order effect. Additionally, close-grip row repetitions to failure were greater in the CHO-BCAA condition compared to the other conditions. | ||
| Welikonich [ | RCT: | Fed (standardized liquid meal 5 h pre). | Significantly more repetitions in the CHO and CHO-PRO condition (CHO: 136 ± 55/36, respectively) vs. placebo (90 ± 15). However, no difference was observed between groups in total volume of work (CHO: 28,052 ± 19,198 kg vs. CHO-PRO: 24,836 ± 9737 vs. placebo: 15,934 ± 3276 kg ( | ||
| Wilburn et al. [ | Crossover: | Fed (3 h pre, instructed not to change dietary habits). | No significant differences between conditions (total repetitions CHO: 52 ± 7, placebo: 54 ± 8, |
Figure 2Acute carbohydrate intake and effect on strength performance. ↑: “Greater performance for”.
The effect of exercise-induced glycogen depletion and carbohydrate manipulation on acute strength performance.
| Study | Design and Population | Training Protocol and Performance Outcomes | Carbohydrate- (CHO) Intakes | Fasted or Fed | Results |
|---|---|---|---|---|---|
| Haff et al. [ | Counterbalanced crossover: Strength-trained men ( | Both conditions received a standardized high-carbohydrate (~1.2 g/kg) lunch 2.5 h prior to strength tests (~825 kcal). | Fed (2.5 h pre). | Significantly more repetitions and sets to failure in the CHO condition (total repetitions CHO: 199 ± 115 vs. placebo: 131 ± 67, total sets CHO: 19 ± 12 vs. placebo: 11 ± 7). There was no significant difference in the total work performed between conditions, but a tendency for a difference in favor of the CHO condition (336 ± 217 vs. placebo: 224 ± 114, | |
| Haff et al. [ | Crossover: | Fed | No significant differences in the isokinetic measurements between conditions. | ||
| Leveritt and Abernethy [ | Crossover: | Not specified. | Significantly more repetitions at set 1 and 2 during squats in the control diet group compared to the low-carbohydrate diet (set 1: CHO: 18 ± 8, control: 12 ± 5, set 2: CHO: 14 ± 6, control: 10 ± 4. No significant difference was observed in set 3 (CHO: 10 ± 7, control: 11 ± 4) or in torque during knee extensions. | ||
| Mitchell et al. [ | Counterbalanced crossover: | Not specified. | No significant differences in total training volume between groups (high-carbohydrate: ~15,800 kg, low-carbohydrate: ~15,500 kg). | ||
| Oliver et al. [ | Crossover: | Fasted (overnight 12 h). | The carbohydrate conditions achieved significantly greater average power outputs and movement velocities than placebo, but the differences between groups in total training volume or average force output were insignificant or of ‘trivial’ magnitude. | ||
| Symons and Jacobs [ | Counterbalanced crossover: | No significant differences between groups in any of the performance measurements. |
Figure 3Exercise-induced glycogen depletion prior to carbohydrate intake and strength performance tests. ↑: “Greater performance for”.
The effect of short-term (2–7 days) carbohydrate manipulation on acute strength performance.
| Study | Design and Population | Training Protocol and Performance Outcomes | Diet | Results |
|---|---|---|---|---|
|
| ||||
| Dipla et al. [ | Counterbalanced crossover: | No significant differences in peak torque or muscle fatigue between groups. | ||
|
| ||||
| Escobar et al. [ | RCT: | No significant differences between groups in number of repetitions during CrossFit training. | ||
| Hatfield et al. [ | Counterbalanced crossover: | No significant differences between groups in any of the performance measurements. | ||
| Kreider et al. [ | RCT: | No significant differences between groups in any of the performance measurements. | ||
| Meirelles et al. [ | RCT: | No significant differences between groups in any of the isokinetic measurements. | ||
| Moura et al. [ | RCT: | No significant differences between groups in number of repetitions. | ||
| Sawyer et al. [ | Crossover: | Significantly greater handgrip strength, squat 1 RM, and vertical jump height in the carbohydrate restricted condition compared to the control condition, with no difference in the other measurements. | ||
Figure 4Short-term carbohydrate manipulation on strength performance. ↑: “Greater performance for”.
The effect of longer-term carbohydrate diets and strength training on changes in strength performance.
| Study | Design and Population | Strength Training and Performance Outcomes | Diet | Results |
|---|---|---|---|---|
|
| ||||
| Greene et al. [ | Crossover: | No significant difference between groups in changes in 1 RM. | ||
| Gregory et al. [ | RCT: | No significant differences between groups in changes of any of the performance measurements. | ||
| Meirelles and Gomes [ | CT: | No significant differences between groups in changes in any of the 10 RM tests. | ||
| Michalski et al. [ | Female and male CrossFit athletes ( | No significant differences between groups in CrossFit repetition performance. | ||
| Paoli et al. [ | RCT: | No significant differences between groups in 1 RM changes. | ||
| Van Zant et al. [ | Crossover: | No significant differences between groups in changes of any of the performance measurements. | ||
| Vidić et al. [ | RCT: | No significant differences between groups in 1 RM changes. | ||
| Wilson et al. [ | RCT: | No significant differences between groups in changes of any of the performance measurements. | ||
|
| ||||
| De Oliveira et al. [ | RCT: | No significant differences between groups in changes of 1 RM or peak torque. | ||
| Kreider et al. [ | RCT: | No significant differences between groups in changes in repetitions to failure or 1 RM. | ||
| Rhyu and Cho [ | RCT: | No significant differences between groups in changes in any performance outcomes, except for a significantly lower (better) anaerobic fatigue index during the Wingate test in the ketogenic group. | ||
|
| ||||
| Rozenek et al. [ | RCT: | No significant differences between groups in changes of maximal strength. | ||
|
| ||||
| Agee [ | RCT: | No significant differences between groups in changes of maximal strength. | ||
| Kephart et al. [ | CT: | No significant differences between groups in changes of any of the performance measurements. | ||
| LaFountain et al. [ | CT: | No significant differences between groups in changes of any of the performance measurements. | ||
| Paoli et al. [ | Crossover: | No significant differences between groups in changes of any of the performance tests. | ||
| Vargas-Molina et al. [ | RCT: | Significantly greater increase in changes of 1 RM for squat and bench press in the non-ketogenic diet group (10- and 3.3 kg difference, respectively), with no group differences in CMJ performance. | ||
Figure 5Long-term carbohydrate manipulation on strength adaptations. ↑: “Greater performance for”.